PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.
PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:
- Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
- Assessment of regulatory needs (ARN).
- Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.
A summary of all the substance-specific activities can be found under ‘Details’ for each entry.
Further information
- Understanding PACT
- Integrated Regulatory Strategy
- Substances of potential concern
- Dossier Evaluation status
- Substance evaluation
- Endocrine disruptor assessment
- PBT assessment
- Assessment of regulatory needs list
- Registry of CLH intentions until outcome
- Registry of SVHC intentions until outcome
- Recommendations for inclusion in the Authorisation list
- Registry of restriction intentions until outcome
Filter the list
The List does not contain any Substances.
| Data generation and assessment | ARN | Regulatory risk management | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dapsone | 201-248-4 | 80-08-0 | 1 | - | 2 | 1 | - | - | - | - | - | Details |
| Cyclohexylhydroxydiazene 1-oxide, potassium salt (This entry also covers the hydrated forms of K-HDO) | 613-953-8 | 66603-10-9 | - | - | - | 1 | - | 1 | - | - | - | Details |
| Cyanamide | 206-992-3 | 420-04-2 | - | - | - | 1 | - | 1 | - | - | - | Details |
| Copper | 231-159-6 | 7440-50-8 | - | - | 1 | 1 | - | 2 | - | - | - | Details |
| Climbazole | 253-775-4 | 38083-17-9 | 1 | - | 3 | 1 | - | - | - | - | - | Details |
| chlorfenapyr (ISO); 4-bromo-2-(4-chlorophenyl)-1- ethoxymethyl-5-trifluoromethylpyrrole-3-carbonitrile | 602-782-4 | 122453-73-0 | - | - | - | 1 | - | 1 | - | - | - | Details |
| Chloramide | 234-217-9 | 10599-90-3 | - | - | - | 1 | - | - | - | - | - | Details |
| Carbon disulphide | 200-843-6 | 75-15-0 | 1 | - | 1 | 1 | 1 | - | - | - | - | Details |
| butyl 4-hydroxybenzoate | 202-318-7 | 94-26-8 | - | - | - | 1 | 1 | - | 1 | - | - | Details |
| Butanoic acid, 4-amino-4-oxosulfo-, N-coco alkyl derivs., monosodium salts, compds. with triethanolamine | 308-662-5 | 98171-53-0 | 1 | - | - | 1 | 1 | - | - | - | - | Details |